Epigenetics-by-Sex Interaction for Coronary Artery Disease Risk Conferred by the Cystathionine γ-Lyase Gene Promoter Methylation

Efstathia Giannakopoulou, Fotios Konstantinou, Georgia Ragia, Anna Tavridou, Makrina Karaglani, Ekaterini Chatzaki, Andreas Papapetropoulos, Dimitrios Mikroulis, Vangelis G. Manolopoulos

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Coronary artery disease (CAD) is a major global health burden whereby gene-by-environment-by-sex interactions play an important role. Coronary artery bypass graft (CABG) surgery involves patients with well-documented and severe CAD. Hence, the study of CAD in a context of the CABG surgery serves as an advantageous model for disease phenotype ascertainment and genetic association studies. We report here new observations from a case-control genetic association study on promoter methylation of the cystathionine γ-lyase (CTH) gene and its association with CAD. To the best of our knowledge, this is the first clinical study to show the DNA methylation status of the CTH promoter in relation to this clinical phenotype. CTH encodes for the hydrogen sulfide generating enzyme named CSE in the endothelium that is mechanistically highly relevant for CAD. In a sample of 334 subjects from Greece (178 cases with CAD and who underwent CABG, and 156 controls), CTH promoter methylation was analyzed using a SYBR Green-based quantitative methylation-specific polymerase chain reaction. We found increased methylation in CTH promoter in cases (19.1%) compared to controls (10.3%) (p = 0.024). Gene-by-sex analysis sustained the significant association in men (p = 0.032) but not in women (p = 0.884). By using multivariate analyses after controlling for potential confounders such as smoking, age, and gender, we found that increased CTH gene promoter methylation was associated with CAD in the total sample (odds ratio [OR] = 2.163, 95% confidence interval [CI] 1.038-4.506, p = 0.039) and in men (OR = 2.418, 95% CI 1.048-5.581, p = 0.039) but not in women (OR = 0.542, 95% CI 0.094-3.140, p = 0.495). These observations collectively warrant further precision medicine and biomarker research to examine the CTH methylation status as a putative epigenetic regulator of CAD risk in larger and independent samples.

Original languageEnglish (US)
Pages (from-to)741-748
Number of pages8
JournalOMICS A Journal of Integrative Biology
Volume21
Issue number12
DOIs
StatePublished - Dec 1 2017
Externally publishedYes

Fingerprint

Cystathionine
Lyases
Methylation
Epigenomics
Coronary Artery Disease
Genes
Coronary Artery Bypass
Association reactions
Grafts
Odds Ratio
Genetic Association Studies
Confidence Intervals
Transplants
Surgery
Phenotype
Gene-Environment Interaction
Hydrogen Sulfide
Precision Medicine
Greece
DNA Methylation

Keywords

  • biomarkers
  • coronary artery disease
  • CTH genetic variation
  • cystathionine c-lyase
  • diagnostics innovation
  • epigenetics
  • precision medicine

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

Giannakopoulou, E., Konstantinou, F., Ragia, G., Tavridou, A., Karaglani, M., Chatzaki, E., ... Manolopoulos, V. G. (2017). Epigenetics-by-Sex Interaction for Coronary Artery Disease Risk Conferred by the Cystathionine γ-Lyase Gene Promoter Methylation. OMICS A Journal of Integrative Biology, 21(12), 741-748. https://doi.org/10.1089/omi.2017.0149

Epigenetics-by-Sex Interaction for Coronary Artery Disease Risk Conferred by the Cystathionine γ-Lyase Gene Promoter Methylation. / Giannakopoulou, Efstathia; Konstantinou, Fotios; Ragia, Georgia; Tavridou, Anna; Karaglani, Makrina; Chatzaki, Ekaterini; Papapetropoulos, Andreas; Mikroulis, Dimitrios; Manolopoulos, Vangelis G.

In: OMICS A Journal of Integrative Biology, Vol. 21, No. 12, 01.12.2017, p. 741-748.

Research output: Contribution to journalArticle

Giannakopoulou, E, Konstantinou, F, Ragia, G, Tavridou, A, Karaglani, M, Chatzaki, E, Papapetropoulos, A, Mikroulis, D & Manolopoulos, VG 2017, 'Epigenetics-by-Sex Interaction for Coronary Artery Disease Risk Conferred by the Cystathionine γ-Lyase Gene Promoter Methylation', OMICS A Journal of Integrative Biology, vol. 21, no. 12, pp. 741-748. https://doi.org/10.1089/omi.2017.0149
Giannakopoulou, Efstathia ; Konstantinou, Fotios ; Ragia, Georgia ; Tavridou, Anna ; Karaglani, Makrina ; Chatzaki, Ekaterini ; Papapetropoulos, Andreas ; Mikroulis, Dimitrios ; Manolopoulos, Vangelis G. / Epigenetics-by-Sex Interaction for Coronary Artery Disease Risk Conferred by the Cystathionine γ-Lyase Gene Promoter Methylation. In: OMICS A Journal of Integrative Biology. 2017 ; Vol. 21, No. 12. pp. 741-748.
@article{f9f484597f6148c9bdf03007e4421efd,
title = "Epigenetics-by-Sex Interaction for Coronary Artery Disease Risk Conferred by the Cystathionine γ-Lyase Gene Promoter Methylation",
abstract = "Coronary artery disease (CAD) is a major global health burden whereby gene-by-environment-by-sex interactions play an important role. Coronary artery bypass graft (CABG) surgery involves patients with well-documented and severe CAD. Hence, the study of CAD in a context of the CABG surgery serves as an advantageous model for disease phenotype ascertainment and genetic association studies. We report here new observations from a case-control genetic association study on promoter methylation of the cystathionine γ-lyase (CTH) gene and its association with CAD. To the best of our knowledge, this is the first clinical study to show the DNA methylation status of the CTH promoter in relation to this clinical phenotype. CTH encodes for the hydrogen sulfide generating enzyme named CSE in the endothelium that is mechanistically highly relevant for CAD. In a sample of 334 subjects from Greece (178 cases with CAD and who underwent CABG, and 156 controls), CTH promoter methylation was analyzed using a SYBR Green-based quantitative methylation-specific polymerase chain reaction. We found increased methylation in CTH promoter in cases (19.1{\%}) compared to controls (10.3{\%}) (p = 0.024). Gene-by-sex analysis sustained the significant association in men (p = 0.032) but not in women (p = 0.884). By using multivariate analyses after controlling for potential confounders such as smoking, age, and gender, we found that increased CTH gene promoter methylation was associated with CAD in the total sample (odds ratio [OR] = 2.163, 95{\%} confidence interval [CI] 1.038-4.506, p = 0.039) and in men (OR = 2.418, 95{\%} CI 1.048-5.581, p = 0.039) but not in women (OR = 0.542, 95{\%} CI 0.094-3.140, p = 0.495). These observations collectively warrant further precision medicine and biomarker research to examine the CTH methylation status as a putative epigenetic regulator of CAD risk in larger and independent samples.",
keywords = "biomarkers, coronary artery disease, CTH genetic variation, cystathionine c-lyase, diagnostics innovation, epigenetics, precision medicine",
author = "Efstathia Giannakopoulou and Fotios Konstantinou and Georgia Ragia and Anna Tavridou and Makrina Karaglani and Ekaterini Chatzaki and Andreas Papapetropoulos and Dimitrios Mikroulis and Manolopoulos, {Vangelis G.}",
year = "2017",
month = "12",
day = "1",
doi = "10.1089/omi.2017.0149",
language = "English (US)",
volume = "21",
pages = "741--748",
journal = "OMICS A Journal of Integrative Biology",
issn = "1536-2310",
publisher = "Mary Ann Liebert Inc.",
number = "12",

}

TY - JOUR

T1 - Epigenetics-by-Sex Interaction for Coronary Artery Disease Risk Conferred by the Cystathionine γ-Lyase Gene Promoter Methylation

AU - Giannakopoulou, Efstathia

AU - Konstantinou, Fotios

AU - Ragia, Georgia

AU - Tavridou, Anna

AU - Karaglani, Makrina

AU - Chatzaki, Ekaterini

AU - Papapetropoulos, Andreas

AU - Mikroulis, Dimitrios

AU - Manolopoulos, Vangelis G.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Coronary artery disease (CAD) is a major global health burden whereby gene-by-environment-by-sex interactions play an important role. Coronary artery bypass graft (CABG) surgery involves patients with well-documented and severe CAD. Hence, the study of CAD in a context of the CABG surgery serves as an advantageous model for disease phenotype ascertainment and genetic association studies. We report here new observations from a case-control genetic association study on promoter methylation of the cystathionine γ-lyase (CTH) gene and its association with CAD. To the best of our knowledge, this is the first clinical study to show the DNA methylation status of the CTH promoter in relation to this clinical phenotype. CTH encodes for the hydrogen sulfide generating enzyme named CSE in the endothelium that is mechanistically highly relevant for CAD. In a sample of 334 subjects from Greece (178 cases with CAD and who underwent CABG, and 156 controls), CTH promoter methylation was analyzed using a SYBR Green-based quantitative methylation-specific polymerase chain reaction. We found increased methylation in CTH promoter in cases (19.1%) compared to controls (10.3%) (p = 0.024). Gene-by-sex analysis sustained the significant association in men (p = 0.032) but not in women (p = 0.884). By using multivariate analyses after controlling for potential confounders such as smoking, age, and gender, we found that increased CTH gene promoter methylation was associated with CAD in the total sample (odds ratio [OR] = 2.163, 95% confidence interval [CI] 1.038-4.506, p = 0.039) and in men (OR = 2.418, 95% CI 1.048-5.581, p = 0.039) but not in women (OR = 0.542, 95% CI 0.094-3.140, p = 0.495). These observations collectively warrant further precision medicine and biomarker research to examine the CTH methylation status as a putative epigenetic regulator of CAD risk in larger and independent samples.

AB - Coronary artery disease (CAD) is a major global health burden whereby gene-by-environment-by-sex interactions play an important role. Coronary artery bypass graft (CABG) surgery involves patients with well-documented and severe CAD. Hence, the study of CAD in a context of the CABG surgery serves as an advantageous model for disease phenotype ascertainment and genetic association studies. We report here new observations from a case-control genetic association study on promoter methylation of the cystathionine γ-lyase (CTH) gene and its association with CAD. To the best of our knowledge, this is the first clinical study to show the DNA methylation status of the CTH promoter in relation to this clinical phenotype. CTH encodes for the hydrogen sulfide generating enzyme named CSE in the endothelium that is mechanistically highly relevant for CAD. In a sample of 334 subjects from Greece (178 cases with CAD and who underwent CABG, and 156 controls), CTH promoter methylation was analyzed using a SYBR Green-based quantitative methylation-specific polymerase chain reaction. We found increased methylation in CTH promoter in cases (19.1%) compared to controls (10.3%) (p = 0.024). Gene-by-sex analysis sustained the significant association in men (p = 0.032) but not in women (p = 0.884). By using multivariate analyses after controlling for potential confounders such as smoking, age, and gender, we found that increased CTH gene promoter methylation was associated with CAD in the total sample (odds ratio [OR] = 2.163, 95% confidence interval [CI] 1.038-4.506, p = 0.039) and in men (OR = 2.418, 95% CI 1.048-5.581, p = 0.039) but not in women (OR = 0.542, 95% CI 0.094-3.140, p = 0.495). These observations collectively warrant further precision medicine and biomarker research to examine the CTH methylation status as a putative epigenetic regulator of CAD risk in larger and independent samples.

KW - biomarkers

KW - coronary artery disease

KW - CTH genetic variation

KW - cystathionine c-lyase

KW - diagnostics innovation

KW - epigenetics

KW - precision medicine

UR - http://www.scopus.com/inward/record.url?scp=85038900102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038900102&partnerID=8YFLogxK

U2 - 10.1089/omi.2017.0149

DO - 10.1089/omi.2017.0149

M3 - Article

VL - 21

SP - 741

EP - 748

JO - OMICS A Journal of Integrative Biology

JF - OMICS A Journal of Integrative Biology

SN - 1536-2310

IS - 12

ER -